Personalised mRNA-based vaccine trial shows encouraging results for melanoma
Phase 3 trial results for an experimental vaccine based on mRNA technology indicate positive initial outcomes for treating high-risk melanoma patients, potentially representing the arrival of a unique form of cancer therapy...



